DBEF - ETF AI Analysis

Top Page

Xtrackers MSCI EAFE Hedged Equity ETF (DBEF)

Rating:65Neutral

Price Target:―

DBEF, the Xtrackers MSCI EAFE Hedged Equity ETF, earns a solid overall rating thanks to several high-quality global leaders like AstraZeneca, Novartis, HSBC, and Toyota, which all show strong financial health, positive earnings calls, and generally supportive valuations. These strengths are slightly offset by holdings such as Shell and Commonwealth Bank of Australia, where weaker technical trends, revenue or cash flow challenges, and valuation concerns introduce some risk, and investors should also note the fund’s reliance on large non-U.S. companies, which concentrates exposure in developed international markets.

Positive Factors

Broad International Diversification

The fund spreads its investments across many developed markets like Japan, the UK, and Europe, helping reduce the impact of weakness in any single country.

Balanced Sector Mix

Holdings are spread across financials, industrials, health care, technology, and other sectors, which can help smooth out returns when one industry is struggling.

Generally Solid Recent Performance

The ETF has shown steady gains over the past month, three months, and year-to-date, indicating recent positive momentum.

Negative Factors

Moderate Fee Level

The expense ratio is not especially low for a large index-based ETF, which slightly reduces the net return investors keep over time.

Mixed Performance Among Top Holdings

While some major positions like ASML and Toyota have performed strongly, others such as SAP, Nestlé, and Shell have been weaker, which can drag on overall results.

Heavy Tilt Toward Financials and Industrials

A large share of the portfolio is in financial and industrial stocks, which could hurt performance if these economically sensitive sectors face a downturn.

DBEF vs. SPDR S&P 500 ETF (SPY)

AUM8.44B

RegionDeveloped Markets

Expense Ratio0.35%

Beta0.71

IssuerXtrackers

Inception DateJun 09, 2011

Dividend Yield5.36%

Asset ClassEquity

Index TrackedMSCI EAFE 100% Hedged to USD Net Variant

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume825,580

30 Day Avg. Volume809,848

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

56.65

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering686

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

DBEF Summary

DBEF is an ETF that follows the MSCI EAFE index, which covers large and mid-sized companies in developed markets outside North America, like Europe and Japan, while trying to reduce the impact of foreign currency swings against the U.S. dollar. It owns many well-known international companies such as Nestlé, Toyota, and ASML, giving investors broad global diversification across many sectors, including financials, industrials, and healthcare. Someone might invest in DBEF to spread their money across many countries and industries without taking on as much currency risk. However, its value can still go up and down with international stock markets.

How much will it cost me?The Xtrackers MSCI EAFE Hedged Equity ETF (DBEF) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it includes a currency hedging strategy to reduce the impact of exchange rate fluctuations. This added feature makes it a bit more expensive but can be valuable for international investors seeking stability.

What would affect this ETF?The DBEF ETF could benefit from economic growth in developed markets outside North America, particularly in Europe and Asia, as well as strong performance in sectors like financials and industrials, which make up a significant portion of its holdings. However, it may face challenges from global economic slowdowns, regulatory changes in key regions, or sector-specific risks such as fluctuating energy prices impacting companies like Shell. Additionally, while its currency hedging strategy helps mitigate exchange rate risks, unexpected shifts in currency policies or geopolitical tensions could still impact overall returns.

DBEF Top 10 Holdings

DBEF’s story is all about big overseas blue chips doing the heavy lifting while currency noise is kept on mute. ASML has been a powerful engine, with rising momentum that helps pull the fund higher, while a trio of pharma giants—Roche, AstraZeneca, and Novartis—gives the ETF a steady health care backbone that’s been quietly climbing. Financials like HSBC and Mitsubishi UFJ add another leg of support, though Siemens has been more mixed lately. Overall, it’s a diversified, developed-markets ex‑U.S. play with notable strength in Europe and Japan.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	2.40%	$200.48M	€438.14B	72.70%	76 Outperform
ROG	Roche Holding AG	1.43%	$119.53M	CHF272.90B	26.73%	73 Outperform
NOVN	Novartis AG	1.40%	$117.07M	CHF234.59B	22.14%	80 Outperform
AZN	AstraZeneca	1.40%	$116.81M	$298.83B	20.11%	80 Outperform
HSBA	HSBC Holdings	1.33%	$110.99M	£213.83B	42.06%	80 Outperform
NESN	Nestlé SA	1.24%	$103.20M	CHF202.95B	0.58%	71 Outperform
SHEL	Shell (UK)	1.11%	$92.63M	£176.52B	22.65%	73 Outperform
7203	Toyota Motor	0.98%	$81.90M	¥45.81T	23.81%	80 Outperform
SAP	SAP SE	0.97%	$81.17M	€196.68B	-32.79%	66 Neutral
CBA	Commonwealth Bank of Australia	0.94%	$78.62M	AU$288.33B	16.14%	64 Neutral

DBEF Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

50.26

Negative

100DMA

48.56

Positive

200DMA

46.16

Positive

Market Momentum

MACD

0.08

Positive

RSI

36.86

Neutral

STOCH

25.01

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DBEF, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 51.43, equal to the 50-day MA of 50.26, and equal to the 200-day MA of 46.16, indicating a neutral trend. The MACD of 0.08 indicates Positive momentum. The RSI at 36.86 is Neutral, neither overbought nor oversold. The STOCH value of 25.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DBEF.

DBEF Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
DBEF	―	―	$8.44B	0.35%	65 Neutral
JIRE	―	―	$9.94B	0.24%	68 Neutral
FENI	―	―	$8.10B	0.28%	66 Neutral
BBIN	―	―	$6.06B	0.07%	67 Neutral
EFAV	―	―	$5.48B	0.20%	62 Neutral
IHDG	―	―	$2.26B	0.58%	66 Neutral

Performance Comparison

DBEF

Xtrackers MSCI EAFE Hedged Equity ETF

49.82

8.81

21.48%

JIRE

JPMorgan International Research Enhanced Equity ETF

―

FENI

Fidelity Enhanced International ETF

―

BBIN

JPMorgan BetaBuilders International Equity ETF

―

EFAV

iShares MSCI EAFE Min Vol Factor ETF

―

IHDG

WisdomTree International Hedged Quality Dividend Growth Fund

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents